×
About 37,844 results

ALLMedicine™ Mycobacterium Tuberculosis Center

Research & Reviews  18,789 results

Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tub...
https://doi.org/10.1164/rccm.v203retraction1
American Journal of Respiratory and Critical Care Medicine;

Apr 15th, 2021 - Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques.|2021||

Sputum microbiota as a potential diagnostic marker for multidrug-resistant tuberculosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040397
International Journal of Medical Sciences; Lin D, Wang X et. al.

Apr 14th, 2021 - The prevalence of drug-resistant Mycobacterium tuberculosis (Mtb) strains makes disease control more complicated, which is the main cause of death in tuberculosis (TB) patients. Early detection and timely standard treatment are the key to current ...

Disputed rpoB mutations in Mycobacterium tuberculosis and tuberculosis treatment outcomes.
https://doi.org/10.1128/AAC.01573-20
Antimicrobial Agents and Chemotherapy; Lin WH, Lee WT et. al.

Apr 13th, 2021 - Discordant results for Mycobacterium tuberculosis isolates with disputed mutations between genotypic drug susceptibility testing (DST) (gDST) and phenotypic DST (pDST) impact RIF-resistant (RR) and multidrug-resistant (MDR) tuberculosis (TB) treat...

Tissue resident-like CD4+ T cells secreting IL-17 control Mycobacteria tuberculosis in ...
https://doi.org/10.1172/JCI142014
The Journal of Clinical Investigation; Ogongo P, Tezera LB et. al.

Apr 13th, 2021 - T cell immunity is essential for the control of tuberculosis (TB), an important disease of the lung, and is generally studied in humans using peripheral blood cells. Mounting evidence, however, indicates that tissue resident memory T cells (Trm) a...

MPT64 assays for the rapid detection of Mycobacterium tuberculosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035777
BMC Infectious Diseases; Cao XJ, Li YP et. al.

Apr 11th, 2021 - Tuberculosis (TB) is a serious infectious disease caused by Mycobacterium tuberculosis (MTB). An estimated 1.7 billion people worldwide are infected with Mycobacterium tuberculosis (LTBI) during the incubation period without any obvious symptoms. ...

see more →

Guidelines  29 results

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
https://www.nejm.org/doi/full/10.1056/NEJMoa1909953
The New England Journal of Medicine; Tait,D.,et al

Oct 28th, 2019 - BACKGROUND Results of an earlier analysis of a trial of the M72/AS01E candidate vaccine against Mycobacterium tuberculosis showed that in infected adults, the vaccine provided 54.0% protection against active pulmonary tuberculosis disease, without...

Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommend...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522077
MMWR. Morbidity and Mortality Weekly Report; Sosa LE, Njie GJ et. al.

May 17th, 2019 - The 2005 CDC guidelines for preventing Mycobacterium tuberculosis transmission in health care settings include recommendations for baseline tuberculosis (TB) screening of all U.S. health care personnel and annual testing for health care personnel ...

Tuberculosis - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK441916/

Feb 5th, 2019 - Tuberculosis (TB) is an ancient human disease caused by Mycobacterium tuberculosis which mainly affects the lungs, making pulmonary disease the most common presentation (K Zaman, 2010). However, TB is a multi-systemic disease with a protean presen...

Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023184
MMWR. Morbidity and Mortality Weekly Report; Borisov AS, Bamrah Morris S et. al.

Jun 28th, 2018 - Treatment of latent tuberculosis infection (LTBI) is critical to the control and elimination of tuberculosis disease (TB) in the United States. In 2011, CDC recommended a short-course combination regimen of once-weekly isoniazid and rifapentine fo...

Guidelines for Environmental Infection Control in Health-Care Facilities
https://www.cdc.gov/infectioncontrol/pdf/guidelines/environmental-guidelines.pdf

Feb 14th, 2017 - Although the environment serves as a reservoir for a variety of microorganisms, it is rarely implicated in disease transmission except in the immunocompromised population. Inadvertent exposures to environmental opportunistic pathogens (e.

see more →

Drugs  11 results see all →

Clinicaltrials.gov  18,891 results

Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tub...
https://doi.org/10.1164/rccm.v203retraction1
American Journal of Respiratory and Critical Care Medicine;

Apr 15th, 2021 - Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques.|2021||

Sputum microbiota as a potential diagnostic marker for multidrug-resistant tuberculosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040397
International Journal of Medical Sciences; Lin D, Wang X et. al.

Apr 14th, 2021 - The prevalence of drug-resistant Mycobacterium tuberculosis (Mtb) strains makes disease control more complicated, which is the main cause of death in tuberculosis (TB) patients. Early detection and timely standard treatment are the key to current ...

Disputed rpoB mutations in Mycobacterium tuberculosis and tuberculosis treatment outcomes.
https://doi.org/10.1128/AAC.01573-20
Antimicrobial Agents and Chemotherapy; Lin WH, Lee WT et. al.

Apr 13th, 2021 - Discordant results for Mycobacterium tuberculosis isolates with disputed mutations between genotypic drug susceptibility testing (DST) (gDST) and phenotypic DST (pDST) impact RIF-resistant (RR) and multidrug-resistant (MDR) tuberculosis (TB) treat...

Tissue resident-like CD4+ T cells secreting IL-17 control Mycobacteria tuberculosis in ...
https://doi.org/10.1172/JCI142014
The Journal of Clinical Investigation; Ogongo P, Tezera LB et. al.

Apr 13th, 2021 - T cell immunity is essential for the control of tuberculosis (TB), an important disease of the lung, and is generally studied in humans using peripheral blood cells. Mounting evidence, however, indicates that tissue resident memory T cells (Trm) a...

MPT64 assays for the rapid detection of Mycobacterium tuberculosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035777
BMC Infectious Diseases; Cao XJ, Li YP et. al.

Apr 11th, 2021 - Tuberculosis (TB) is a serious infectious disease caused by Mycobacterium tuberculosis (MTB). An estimated 1.7 billion people worldwide are infected with Mycobacterium tuberculosis (LTBI) during the incubation period without any obvious symptoms. ...

see more →

News  123 results

Does Your Patient Have Latent TB Infection? Test Your Knowledge
https://www.medscape.com/viewarticle/945495

Feb 11th, 2021 - More than 80% of tuberculosis (TB) cases in the United States are a result of untreated latent TB infection that progresses to TB disease. The Centers for Disease Control and Prevention (CDC) estimates that up to 13 million people in the United St...

To Improve TB Vaccination, Change The Way It’s Given?
https://www.mdedge.com/fedprac/article/217182/vaccines/improve-tb-vaccination-change-way-its-given?channel=94
Jan Dyer

Feb 14th, 2020 - The standard intradermal route of delivery for Bacille Calmette–Guérin (BCG) does not necessarily generate a strong enough response from lung T-cells, the researchers say. They hypothesized that administering BCG by IV or aerosol might be more eff.

Nontuberculous Mycobacterial Pulmonary Disease
https://www.mdedge.com/pulmonary-health-hub/article/216435/pulmonology/nontuberculous-mycobacterial-pulmonary-disease?channel=284&channel=28687
Juzar Ali, MD, FRCP(C), FCCP

Feb 5th, 2020 - Nontuberculous mycobacterial pulmonary disease is a broad term for a group of pulmonary disorders caused and characterized by exposure to environmental mycobacteria other than those belonging to the Mycobacterium tuberculosis complex and Mycobacte.

Papulonecrotic Tuberculid Secondary to Mycobacterium avium Complex
https://www.mdedge.com/dermatology/article/212703/infectious-diseases/papulonecrotic-tuberculid-secondary-mycobacterium?channel=44
Brittany Urso, MD, Corey Georgesen, MD et. al.

Nov 20th, 2019 - To the Editor: Papulonecrotic tuberculid (PNT) is a cutaneous hypersensitivity reaction to antigenic components of Mycobacterium species, most commonly Mycobacterium tuberculosis. According to a PubMed search of articles indexed for MEDLINE using.

Subunit Vaccine Effective Against TB Disease Progression
https://www.medpagetoday.com/infectiousdisease/tuberculosis/83002

Oct 29th, 2019 - In individuals infected with Mycobacterium tuberculosis but without symptoms, a vaccine offered some protection against progression to active tuberculosis disease for at least 3 years in a placebo controlled trial. Final results in the trial testi...

see more →

Patient Education  1 results see all →